InvestorsHub Logo
Followers 62
Posts 7553
Boards Moderated 1
Alias Born 01/02/2003

Re: rosemountbomber post# 385045

Wednesday, 08/03/2022 5:27:36 PM

Wednesday, August 03, 2022 5:27:36 PM

Post# of 426240
Rose..."QUOTE friom KM..."The fixed dose combination or FDC product is in the early stages of development. If successful, the combination therapy would be a game-changer for patients since it will carry the most significant cardiovascular risk outcome benefit label and would hopefully "PROVIDE ADDITIONAL MARKET EXCLUSIVITY"

I am wondering why this is still in "the early stages of development"...rather than having been initiated immediately after the Du decision and the subsequent failed appeals....Someone in management was asleep at the switch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News